These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 34109728)

  • 21. Otilonium Bromide: A Drug with a Complex Mechanism of Action.
    Evangelista S; Traini C; Vannucchi MG
    Curr Pharm Des; 2018; 24(16):1772-1779. PubMed ID: 29732965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations in colonic corticotropin-releasing factor receptors in the maternally separated rat model of irritable bowel syndrome: differential effects of acute psychological and physical stressors.
    O'Malley D; Dinan TG; Cryan JF
    Peptides; 2010 Apr; 31(4):662-70. PubMed ID: 20096320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imipramine improves visceral sensation and gut barrier in rat models of irritable bowel syndrome.
    Nozu T; Miyagishi S; Ishioh M; Takakusaki K; Okumura T
    Eur J Pharmacol; 2020 Nov; 887():173565. PubMed ID: 32946869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phlorizin attenuates visceral hypersensitivity and colonic hyperpermeability in a rat model of irritable bowel syndrome.
    Nozu T; Miyagishi S; Ishioh M; Takakusaki K; Okumura T
    Biomed Pharmacother; 2021 Jul; 139():111649. PubMed ID: 33957565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increase in neurokinin-1 receptor-mediated colonic motor response in a rat model of irritable bowel syndrome.
    La JH; Kim TW; Sung TS; Kim HJ; Kim JY; Yang IS
    World J Gastroenterol; 2005 Jan; 11(2):237-41. PubMed ID: 15633223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antinociceptive effect of chronic lithium on visceral hypersensitivity in a rat model of diarrhea-predominant irritable bowel syndrome: The role of nitric oxide pathway.
    Shamshiri H; Paragomi P; Paydar MJ; Moezi L; Bahadori M; Behfar B; Ardalan FA; Dehpour AR
    J Gastroenterol Hepatol; 2009 Apr; 24(4):672-80. PubMed ID: 19032458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome.
    Clavé P; Acalovschi M; Triantafillidis JK; Uspensky YP; Kalayci C; Shee V; Tack J;
    Aliment Pharmacol Ther; 2011 Aug; 34(4):432-42. PubMed ID: 21679214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Corticotropin-releasing factor receptor 1 (CRF-R1) antagonists: Promising agents to prevent visceral hypersensitivity in irritable bowel syndrome.
    Lv Y; Wen J; Fang Y; Zhang H; Zhang J
    Peptides; 2022 Jan; 147():170705. PubMed ID: 34822913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tong Xie Yao Fang relieves irritable bowel syndrome in rats via mechanisms involving regulation of 5-hydroxytryptamine and substance P.
    Yin Y; Zhong L; Wang JW; Zhao XY; Zhao WJ; Kuang HX
    World J Gastroenterol; 2015 Apr; 21(15):4536-46. PubMed ID: 25914462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corticotropin-releasing factor receptor type 1 and type 2 interaction in irritable bowel syndrome.
    Nozu T; Okumura T
    J Gastroenterol; 2015 Aug; 50(8):819-30. PubMed ID: 25962711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Losartan improves visceral sensation and gut barrier in a rat model of irritable bowel syndrome.
    Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
    Neurogastroenterol Motil; 2020 Jun; 32(6):e13819. PubMed ID: 32056324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Irritable bowel syndrome.
    Spinelli A
    Clin Drug Investig; 2007; 27(1):15-33. PubMed ID: 17177577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome.
    Sagami Y; Shimada Y; Tayama J; Nomura T; Satake M; Endo Y; Shoji T; Karahashi K; Hongo M; Fukudo S
    Gut; 2004 Jul; 53(7):958-64. PubMed ID: 15194643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral Guanylate Cyclase-C modulation of corticolimbic activation and corticotropin-releasing factor signaling in a rat model of stress-induced colonic hypersensitivity.
    Ligon CO; Hannig G; Greenwood-Van Meerveld B
    Neurogastroenterol Motil; 2021 Mar; 33(3):e14076. PubMed ID: 33373484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic treatment with otilonium bromide induces changes in L-type Ca²⁺ channel, tachykinins, and nitric oxide synthase expression in rat colon muscle coat.
    Traini C; Cipriani G; Evangelista S; Santicioli P; Faussone-Pellegrini MS; Vannucchi MG
    Neurogastroenterol Motil; 2013 Nov; 25(11):e728-39. PubMed ID: 23901937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in brain G proteins and colonic sympathetic neural signaling in chronic-acute combined stress rat model of irritable bowel syndrome (IBS).
    Zou N; Lv H; Li J; Yang N; Xue H; Zhu J; Qian J
    Transl Res; 2008 Dec; 152(6):283-9. PubMed ID: 19059163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Possible therapeutic role of IgE blockade in irritable bowel syndrome.
    Magen E; Chikovani T
    World J Gastroenterol; 2016 Nov; 22(43):9451-9456. PubMed ID: 27920467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of corticotropin-releasing factor in intestinal mucosal eosinophils is associated with clinical severity in Diarrhea-Predominant Irritable Bowel Syndrome.
    Salvo-Romero E; Martínez C; Lobo B; Rodiño-Janeiro BK; Pigrau M; Sánchez-Chardi AD; González-Castro AM; Fortea M; Pardo-Camacho C; Nieto A; Expósito E; Guagnozzi D; Rodríguez-Urrutia A; de Torres I; Farré R; Azpiroz F; Alonso-Cotoner C; Santos J; Vicario M
    Sci Rep; 2020 Nov; 10(1):20706. PubMed ID: 33244004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation.
    Fukudo S
    J Gastroenterol; 2007 Jan; 42 Suppl 17():48-51. PubMed ID: 17238026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential stress-induced alterations of colonic corticotropin-releasing factor receptors in the Wistar Kyoto rat.
    o'malley D; Julio-Pieper M; Gibney SM; Gosselin RD; Dinan TG; Cryan JF
    Neurogastroenterol Motil; 2010 Mar; 22(3):301-11. PubMed ID: 19807869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.